When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Lilly's weight-loss treatment Zepbound becomes first FDA ...

   www.aol.com/news/lillys-weight-loss-drug...

   (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly ...

3. Zepbound Weight Loss Medication Approved by FDA to Treat ...

   www.aol.com/fda-approves-weight-loss-medication...

   The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.

4. FDA approves weight-loss drug Zepbound for obstructive ... - AOL

   www.aol.com/news/fda-approves-weight-loss-drug...

   Participants on Zepbound also lost significant amounts of weight: about 18% of their body weight, on average, in the first trial and about 20% in the second, compared with 1.6% and 2.3% ...

5. FDA approves weight-loss drug to treat sleep apnea - AOL

   www.aol.com/fda-approves-weight-loss-drug...

   The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...

6. Tirzepatide - Wikipedia

   en.wikipedia.org/wiki/Tirzepatide

   [9] [13] In the United States, it is sold under the brand name Mounjaro for diabetes treatment, [9] and Zepbound for weight loss and treatment of obstructive sleep apnea. [ 10 ] [ 17 ] Tirzepatide is a gastric inhibitory polypeptide analog and GLP-1 receptor agonist . [ 10 ]

7. The popular weight-loss drug Zepbound can now be used to ...

   www.aol.com/news/popular-weight-loss-drug...

   An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City. The Food and Drug Administration approved the drug as a treatment for people with moderate to severe ...